A genetic variant in RASSF1A, a key regulator of HIPPO pathway, predicts survival in two independent cohorts of mCRC patients treated with cetuximab...

Date 28 September 2015
Event European Cancer Congress 2015
Session Gastrointestinal Malignancies - Colorectal Cancer II
Topics Colon Cancer
Rectal Cancer
Presenter Sebio, A.